INKINE PHARMACEUTICAL CO INC
4, 1998-09-10
PHARMACEUTICAL PREPARATIONS
Previous: AUSA ENDEAVOR VARIABLE ANNUITY ACCOUNT, N-30D, 1998-09-10
Next: INKINE PHARMACEUTICAL CO INC, 4, 1998-09-10



<PAGE>   1
                                                    ---------------------------
                                                           OMB APPROVAL        
                                                    ---------------------------
- ------                                              OMB Number:  3235-0287    
FORM 4                                              Expires: September 30, 1998
- ------                                              Estimated average burden   
                                                    hours per response .... 0.5
                                                    ---------------------------

                                 U.S. SECURITIES AND EXCHANGE COMMISSION
                                          WASHINGTON, D.C. 20549
                                       
                               STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
/ / Check this box if no                                                     
    longer subject to         Filed pursuant to Section 16(a) of the Securities 
    Section 16. Form 4            Exchange Act of 1934, Section 17(a) of the 
    or Form 5 obligations         Public Utility Holding Company Act of 1935
    may continue. See              or Section 30(f) of the Investment Company
    Instruction 1(b).                           Act of 1940               

<TABLE> 
<S>                             <C>         <C>          <C>           <C>           <C>      <C>         <C>            <C>
(Print or Type Responses)
- ------------------------------------------------------------------------------------------------------------------------------------
1. Name and Address of Reporting Person*    2. Issuer Name and Ticker or Trading Symbol       6. Relationship of Reporting Person(s)
Apple           Robert              F.           InKine Pharmaceutical Company, Inc. (INKP)      to Issuer (Check all applicable)
- --------------------------------------------------------------------------------------------         Director         10% Owner
(Last)          (First)          (Middle)   3. IRS or Social Security  4.  Statement for         ----              ---
InKine Pharmaceutical Company, Inc.             Number of Reporting         Month/Year            X  Officer (give     Other
Sentry Park East, 1720 Walton Road              Person (Voluntary)          August 1998          ----         title ---(Specify
- --------------------------------------------                               ------------------                below)    below)
                 (Street)                                                                        Vice President, Finance and
                                                                                                 Administration 
                                                                                                 ----------------------------
                                                                       5. If Amendment,       7. Individual or Joint/Group Filing
                                                                             Date of Original    (Check Applicable Line)
                                                                             (Month/Year)     X  Form filed by One Reporting Person
                                                                                              --
                                                                                              -- Form filed by More than One Report-
Blue Bell,      Pennsylvania         19422                                                       ing Person
- ------------------------------------------------------------------------------------------------------------------------------------
  (City)           (State)           (Zip)     

- ------------------------------------------------------------------------------------------------------------------------------------
                                               TABLE 1 -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
- ------------------------------------------------------------------------------------------------------------------------------------
 1. Title of Security           2. Trans-   3. Transac-   4. Securities Acquired (A) 5.  Amount of Se-    6. Owner-      7. Nature  
  (Instr. 3)                       action      tion          or Disposed of (D)          curities Benefi-    ship           of In-  
                                   Date        Code          (Instr. 3, 4 and 5)         cially Owned at     Form:          direct  
                                               (Instr. 8)                                End of Month        Direct         Benefi-
                                  (Month/                                                (Instr. 3 and 4)    (D) or         cial
                                   Day/     ---------------------------------------                          Indirect       Owner- 
                                   Year)      Code    V      Amount  (A) or   Price                          (I)            ship 
                                                                     (D)                                     (Instr. 4)     (Instr.
                                                                                                                            4)

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.                   (Over)
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
                                                                                                                     SEC 1474 (7/96)
</TABLE>

<PAGE>   2
<TABLE>
<CAPTION>
                                                                                                                                
 
FORM 4 (CONTINUED)        TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
                                  (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)

<S>                       <C>          <C>        <C>         <C>              <C>             <C>                   <C>          
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative    2. Conver-   3. Trans-  4. Trans-   5. Number of     6. Date Exer-   7. Title and Amount   8. Price     
   Security                  sion or      action     action      Derivative       cisable and     of Underlying         of        
   (Instr. 3)                Exercise     Date       Code        Securities Ac-   Expiration      Securities            Deriv-    
                             Price of     (Month/    (Instr. 8)  quired (A) or    Date            (Instr. 3 and 4)      ative     
                             Deriv-       Day/                   Disposed of (D)  (Month/Day/                           Secur-    
                             ative        Year)                  (Instr. 3, 4     Year)                                 ity       
                             Security                            and 5)                                                 (Instr. 5)
                                                                               -----------------------------------             
                                                                               Date    Expira-            Amount or            
                                                    -------------------------- Exer-   tion       Title   Number of            
                                                    Code  V     (A)     (D)    cisable Date               Shares               
- ------------------------------------------------------------------------------------------------------------------------------------
Stock Option                                                                                      Common
(Right to Buy)           $1.25            8/3/98       A        10,000         (1)     8/3/08     Stock    10,000
- ------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                          
- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------
<S>                          <C>                    <C>                         <C>                              
1. Title of Derivative       9. Number of           10. Ownership               11. Nature of                              
   Security                     Derivative              Form of                     Indirect                     
   (Instr. 3)                   Securities              Derivative                  Beneficial                   
                                Beneficially            Security:                   Ownership                    
                                Owned at End            Direct (D)                  (Instr. 4)                   
                                of Month                or Indirect (I)                                          
                                (Instr. 4)              (Instr. 4)                                               
                                                                                 
- -------------------------------------------------------------------------------------------------------
Stock Option
(Right to Buy)                  10,000
- -------------------------------------------------------------------------------------------------------
                                50,000(2)
- -------------------------------------------------------------------------------------------------------

- -------------------------------------------------------------------------------------------------------

- -------------------------------------------------------------------------------------------------------

- -------------------------------------------------------------------------------------------------------

- -------------------------------------------------------------------------------------------------------
Explanation of Responses:
 
(1) Option will become exercisable in annual increments of 2,500 shares 
    commencing on August 3, 1999.
(2) Consists of options held prior to the transactions reported hereby. 

**  Intentional misstatements or omissions of facts constitute Federal
     Criminal Violations.                                                     /s/ Robert F. Apple               September 4, 1998
    See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).                                --------------------------------   -----------------
                                                                             **Signature of Reporting Person          Date
                                                                               Robert F. Apple 

Note. File three copies of this Form, one of which must be manually signed.      
      If space provided is insufficient, see Instruction 6 for procedure. 

Potential persons who are to respond to the collection of information contained 
in this form are not required to respond unless the form displays a currently
valid OMB Number.                                                                                                             Page 2
                                                                                                                     SEC 1474 (7-96)
</TABLE>                                                                      




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission